Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne C Koff

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Vaccine|March 9, 2004
Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapyConnie L Finstad, Chang Yi Wang, Jacek Kowalski, et al.
Journal of Virology|January 15, 2016
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 LoopShilpa Patil, Rajesh Kumar, Suprit Deshpande, et al.
Plos One|July 4, 2014
Transplanting supersites of HIV-1 vulnerabilityTongqing Zhou, Jiang Zhu, Yongping Yang, et al.
Journal of Virology|May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodiesNicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.
Vaccine|May 10, 2012
A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challengeMatthew R Reynolds, Andrea M Weiler, Shari M Piaskowski, et al.
Journal of Virology|July 2, 2010
Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challengeMatthew R Reynolds, Andrea M Weiler, Shari M Piaskowski, et al.
Journal of Virology|July 8, 2011
The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challengeMatthew R Reynolds, Jonah B Sacha, Andrea M Weiler, et al.
Science Translational Medicine|February 4, 2021
Development and deployment of COVID-19 vaccines for those most vulnerableWayne C Koff, Theodore Schenkelberg, Tere Williams, et al.
Frontiers in Immunology|November 15, 2021
Machine Learning-Based Single Cell and Integrative Analysis Reveals That Baseline mDC Predisposition Correlates With Hepatitis B Vaccine Antibody ResponseBrian D Aevermann, Casey P Shannon, Mark Novotny, et al.
Plos One|July 7, 2012
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionStephane Champiat, Rui André Saraiva Raposo, Nicholas J Maness, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Vaccine|March 9, 2004
Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapyConnie L Finstad, Chang Yi Wang, Jacek Kowalski, et al.
Journal of Virology|January 15, 2016
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 LoopShilpa Patil, Rajesh Kumar, Suprit Deshpande, et al.
Plos One|July 4, 2014
Transplanting supersites of HIV-1 vulnerabilityTongqing Zhou, Jiang Zhu, Yongping Yang, et al.
Journal of Virology|May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodiesNicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.
Vaccine|May 10, 2012
A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challengeMatthew R Reynolds, Andrea M Weiler, Shari M Piaskowski, et al.
Journal of Virology|July 2, 2010
Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challengeMatthew R Reynolds, Andrea M Weiler, Shari M Piaskowski, et al.
Journal of Virology|July 8, 2011
The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challengeMatthew R Reynolds, Jonah B Sacha, Andrea M Weiler, et al.
Science Translational Medicine|February 4, 2021
Development and deployment of COVID-19 vaccines for those most vulnerableWayne C Koff, Theodore Schenkelberg, Tere Williams, et al.
Frontiers in Immunology|November 15, 2021
Machine Learning-Based Single Cell and Integrative Analysis Reveals That Baseline mDC Predisposition Correlates With Hepatitis B Vaccine Antibody ResponseBrian D Aevermann, Casey P Shannon, Mark Novotny, et al.
Plos One|July 7, 2012
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionStephane Champiat, Rui André Saraiva Raposo, Nicholas J Maness, et al.
Pageof 7